Large Cap
Pharmaceutical Preparations
Stocks Ranked by
Market Capitalization
Filters
# | Name | Market cap | Price | Price change % | |
---|---|---|---|---|---|
1 | 1 Abbott ABT $198B | $198B | $113.86 | +0.67% | |
2 | 2 Pfizer PFE $162B | $162B | $28.56 | +0.03% | |
3 | 3 Regeneron Pharmaceuticals REGN $125B | $125B | $1,131.50 | -1.66% | |
4 | 4 Vertex Pharmaceuticals VRTX $121B | $121B | $468 | -0.12% | |
5 | 5 Bristol-Myers Squibb BMY $98.7B | $98.7B | $48.70 | -2.41% | |
6 | 6 Zoetis ZTS $85.7B | $85.7B | $189.23 | +1.41% | |
7 | 7 Alnylam Pharmaceuticals ALNY $31.7B | $31.7B | $246.78 | -1.87% | |
8 | 8 Teva Pharmaceuticals TEVA $20.5B | $20.5B | $18.08 | -1.9% | |
9 | 9 BeiGene BGNE $20.3B | $20.3B | $191.32 | -0.14% | |
10 | 10 BioMarin Pharmaceuticals BMRN $16B | $16B | $84.08 | -1.67% | |
11 | 11 United Therapeutics UTHR $15.4B | $15.4B | $345.63 | -1.25% | |
12 | 12 Tenet Healthcare THC $15B | $15B | $153.40 | -5.3% | |
13 | 13 Viatris VTRS $13.5B | $13.5B | $11.27 | -3.43% | |
14 | 14 Royalty Pharma RPRX $12.9B | $12.9B | $28.70 | -1.2% | |
15 | 15 Insmed INSM $12.2B | $12.2B | $71.04 | -2.56% | |
16 | 16 Sarepta Therapeutics SRPT $12.2B | $12.2B | $128.92 | -3.63% | |
17 | 17 Catalent CTLT $10.9B | $10.9B | $60.01 | -0.65% |